Type 2 diabetes sits in a chair

Biomedicinsk Institut

Type 2 diabetes sits in a chair

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Type 2 diabetes sits in a chair. / Solomon, Thomas; Thyfault, J P.

I: Diabetes, Obesity and Metabolism Online, Bind 15, Nr. 11, 03.04.2013, s. 987-992.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Solomon, T & Thyfault, JP 2013, 'Type 2 diabetes sits in a chair', Diabetes, Obesity and Metabolism Online, bind 15, nr. 11, s. 987-992. https://doi.org/10.1111/dom.12105

APA

Solomon, T., & Thyfault, J. P. (2013). Type 2 diabetes sits in a chair. Diabetes, Obesity and Metabolism Online, 15(11), 987-992. https://doi.org/10.1111/dom.12105

Vancouver

Solomon T, Thyfault JP. Type 2 diabetes sits in a chair. Diabetes, Obesity and Metabolism Online. 2013 apr. 3;15(11):987-992. https://doi.org/10.1111/dom.12105

Author

Solomon, Thomas ; Thyfault, J P. / Type 2 diabetes sits in a chair. I: Diabetes, Obesity and Metabolism Online. 2013 ; Bind 15, Nr. 11. s. 987-992.

Bibtex

@article{f543fbb1427644759627bd0e317ac5cf,

title = "Type 2 diabetes sits in a chair",

abstract = "The incidence of type 2 diabetes (T2D) continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. 'sitting time') combined with reduced physical activity levels, plays both a major role in the development of T2D and may contribute to the worsening of the condition after diagnosis. In this review, we cover these topics and use current scientific evidence to support our belief that 'type 2 diabetes sits in a chair'. We also discuss a relatively new question that has yet to be examined: Would reducing sitting time be an effective treatment for T2D?",

author = "Thomas Solomon and Thyfault, {J P}",

note = "{\textcopyright} 2013 Blackwell Publishing Ltd.",

year = "2013",

month = apr,

day = "3",

doi = "10.1111/dom.12105",

language = "English",

volume = "15",

pages = "987--992",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "11",

}

RIS

TY - JOUR

T1 - Type 2 diabetes sits in a chair

AU - Solomon, Thomas

AU - Thyfault, J P

PY - 2013/4/3

Y1 - 2013/4/3

N2 - The incidence of type 2 diabetes (T2D) continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. 'sitting time') combined with reduced physical activity levels, plays both a major role in the development of T2D and may contribute to the worsening of the condition after diagnosis. In this review, we cover these topics and use current scientific evidence to support our belief that 'type 2 diabetes sits in a chair'. We also discuss a relatively new question that has yet to be examined: Would reducing sitting time be an effective treatment for T2D?

AB - The incidence of type 2 diabetes (T2D) continues to skyrocket across the industrialized world leading to soaring medical costs, reduced quality of life and increased mortality rates. Therefore, a more firm understanding of the development of the disease and effective, low cost therapies for prevention and treatment are desperately needed. Accumulating evidence suggests that increased sedentary time (i.e. 'sitting time') combined with reduced physical activity levels, plays both a major role in the development of T2D and may contribute to the worsening of the condition after diagnosis. In this review, we cover these topics and use current scientific evidence to support our belief that 'type 2 diabetes sits in a chair'. We also discuss a relatively new question that has yet to be examined: Would reducing sitting time be an effective treatment for T2D?

U2 - 10.1111/dom.12105

DO - 10.1111/dom.12105

M3 - Journal article

C2 - 23551885

VL - 15

SP - 987

EP - 992

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 11

ER -

ID: 49898894